Bio Spectrum Magazine - October 2020Add to Favorites

Bio Spectrum Magazine - October 2020Add to Favorites

Go Unlimited with Magzter GOLD

Read Bio Spectrum along with 8,500+ other magazines & newspapers with just one subscription  View catalog

1 Month $9.99

1 Year$99.99

$8/month

(OR)

Subscribe only to Bio Spectrum

1 Year $10.99

Save 7%

Buy this issue $0.99

Gift Bio Spectrum

7-Day No Questions Asked Refund7-Day No Questions
Asked Refund Policy

 ⓘ

Digital Subscription.Instant Access.

Digital Subscription
Instant Access

Verified Secure Payment

Verified Secure
Payment

In this issue

THE INDIAN E-PHARMACY MANTHAN SAGA

Amazon, Reliance and Flipkart v/s the others…

The question is who will win? Will this pitting of wits drive new innovations in healthcare delivery and add value to customers?

The COVID 19 pandemic has opened up myriad opportunities for digital platforms to tap into India’s lucrative healthcare and pharmaceutical industry. The pharma market alone is one of the largest in the world and is continuing to grow. Given the current situation, there has been a macro trend that indicates a growing need for online pharmacies as more people seek to order their medications online. Moreover, the entry of tech giant Amazon and the acquisition of Netmeds by Reliance gives a clear indication that this sector is all set for a major disruption

India Bracing For Mental Health Crisis

This year, the 29th World Mental Health Day is all the more important for the globe as we find ourselves in the midst of a global mental distress crisis brought by COVID-19. The theme ‘Mental Health for All: Greater Investment- Greater Access’ fits appropriately as the situation not only demands enhanced access to mental health by breaking the stigma but also strengthening investments in the space as supporting pillars.

India Bracing For Mental Health Crisis

8 mins

“The biotechnology industry in India is entering a new era of growth”

The COVID-19 pandemic has unlocked several opportunities for the life sciences sector in India. And in response to this, the sector has taken the right plunge. KPMG’s new report on ‘Site selection for life sciences in Asia’ reveals the true potential has India possess. In an interview, Sanjay Singh, Partner – Deal Advisory, Head of Lifesciences, KPMG, Mumbai, expounds on the key findings of this study and shares insights on key market drivers. Edited excerpts;

“The biotechnology industry in India is entering a new era of growth”

4 mins

“We are in talks with Karnataka to deploy Vevra pods across the state”

To fight the ongoing pandemic and other contagious and airborne diseases, Bengaluru based company Vevra has allied with a Portugal based healthcare IoT company InnoWave Group to introduce artificial intelligence (AI) driven mobile hospital units called Vevra Pods. Primarily born as an answer for major medical crises of any form, these pods consist of a set of movable capsules that aim to efficiently assist in the infrastructure of hospitals across India. Mahesh Krishnahari, Director & Founder, Vevra Group, Bengaluru spoke to BioSpectrum in detail about this innovative solution. Edited excerpts;

“We are in talks with Karnataka to deploy Vevra pods across the state”

2 mins

“We have the capacity to produce over 10M COVID-19 tests per week globally”

Thermo Fisher Scientific, the world leader in serving science, is continuously working to expand global capacity and capabilities across its leading pharma services network to support customers in government, industry and academia as they accelerate development and production of COVID-19 vaccines, therapies and other treatments.

“We have the capacity to produce over 10M COVID-19 tests per week globally”

4 mins

Read all stories from Bio Spectrum

Bio Spectrum Magazine Description:

PublisherMM Activ Sci-Tech Communication

CategoryBusiness

LanguageEnglish

FrequencyMonthly

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.

  • cancel anytimeCancel Anytime [ No Commitments ]
  • digital onlyDigital Only
MAGZTER IN THE PRESS:View All